Delix Inks Deal With Cellectricon; Psyched Wellness Partners With Spacestation
Psychedelics Companies Share Corporate Updates: Numinus, Delix, Tryp And Small Pharma
Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS
Delix Therapeutics Raises $30M In Convertible Note Financing, Will Enhance Drug Development Program
Delix Therapeutics Recent News
National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000
Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction
'Psychedelics Without Hallucinations': Concept Gets Closer To Human Trials With $70M Funding